期刊文献+

三黄凝胶剂的研制及质量控制 被引量:5

SanHuang Gel Preparation and Quality Control
下载PDF
导出
摘要 目的:研究三黄凝胶剂的制备及质量控制。方法:采用卡波姆等为基质制成凝胶剂,并建立质量控制方法,用HPLC法测定凝胶剂中大黄含量,检测波长为365 nm并进行稳定性实验。结果:大黄素进样量在0.002 57~0.051 40μg范围内,与峰面积积分值呈良好的线性关系(r=0.999 5);大黄酚进样量在0.008 61~0.172 20μg范围内,与峰面积积分值呈良好的线性关系(r=0.999 5);大黄素和大黄酚总量的加样平均回收率为98.4%(RSD为1.38%,n=5)。结论:该制剂处方合理,制备工艺简单,稳定性好,质量可控制。 Objective:To study SanHuang gel preparation and quality control.Method:Carbopol the matrix made as gel,and establish quality control methods,determined by HPLC gel content in rhubarb,detection at 365 nm and the stability test.Result:emodin sample volume 0.002 57-0.051 40 μg range,and peak area values showed a good linear relationship(r=0.999 5);chrysophanol sample volume in the range of 0.008 61-0.172 20 μg,and the peak area values showed a good linear relationship(r=0.999 5);emodin and chrysophanol plus the total average recovery was 98.4%(RSD of 1.38%,n = 5).Conclusion:The prescription was reasonable preparation,preparation was simple,good stability,quality control.
机构地区 甘肃中医学院
出处 《西部中医药》 2011年第8期28-30,共3页 Western Journal of Traditional Chinese Medicine
关键词 三黄膏 凝胶剂 高效液相色谱法 SanHuang paste gel high-performance liquid chromatography
  • 相关文献

参考文献3

二级参考文献45

  • 1刘国勤,吕玉麟,石建明,陈铁楼,马晓蓬,刘筠,侯惠民,贺芬.醋酸地塞米松粘贴片的研制[J].海军医学杂志,2000,21(2):138-139. 被引量:12
  • 2庄志铨,李国锋,石兴华.维甲酸-β-环糊精包合物乳膏的研制[J].中国医院药学杂志,1995,15(8):362-363. 被引量:10
  • 3-.中国药典,二部[M].北京:化学工业出版社,2000.附录:69.
  • 4M Kitano, Y Mitani, K Takayama, et al. Buccal absorption of gokden hamster cheed in vitro and in vivo of 17 β - estradiolfrom hydrogels containing three types of absorption enhancers[J].Int J Pharm, 1998,174: 143-152.
  • 5V R Patel, M M Amiji. Preparation and characterization of freezedried chitosan poly (ethylene oxide) semi interpenetrating polymer network with pH-sensityve swelling and enzyme - degradable propertiesfor oral drug delivery[J].Drug Dev Ind Pharm, 1997,23:
  • 6M Amiji, R Tailor, M K Ly, et al. Gelatin- poly(ethylene oxide) semi-interpenetrating polymer network with pH-sensitive swelling and enzyme-degradable properties for oral drug delivery[J]. Drug Dev Ind Pharm, 1997,23: 575-582.
  • 7Y Akiyama. Novel peroral dosages forms with protease inhibitory activities. Ⅱ. Design of fast dissolving poly (acrylate) and controlled drug releasing capsule formulations with trypsin inhibiting properties[J]. Int J Pharm, 1996,138: 13-23.
  • 8S Miyazaki, F Suisha, N Kawasaki. Thermally reversible xyloglucan gels as vehicles for rectal drug delivery[J]. J Control Release, 1999,59: 163-172.
  • 9S Cohen, E Lobel. A novelin situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye[J]. J Contros Release, 1997,44: 201-208.
  • 10J Carlfors, K Edsman. Rheological evaluation of Gelrite in situ gels for ophthasmec use[J]. Eur J Pharm Biopharm, 1998,46:125-132.

共引文献28

同被引文献46

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部